drugset / Trial / NCT06521697

Effects of Minimal-Flow Sevoflurane and Multimodal Analgesia in Head and Neck Cancer Surgery

NCT06521697 ↗

Phase 4 Not yet recruiting 60 enrolled National Taiwan University Hospital
RandomizedFactorialQuadruple-blindPrevention

Summary

This study evaluates the anesthetic-sparing and renal protection effects of minimal-flow sevoflurane anesthesia combined with multimodal analgesia using dexmedetomidine, ketamine, and lidocaine in head and neck cancer patients undergoing free flap microvascular surgery. The 2x2 factorial randomized controlled trial aims to compare sevoflurane usage and renal function changes with different fresh gas flow rates and multimodal analgesia.

Timeline

Start
2024-08
Primary completion
2025-06
Completion
2025-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified — —
Subject Ketamine Small molecule — —
Subject Lidocaine Other / unclassified — —